[
    [
        {
            "time": "2018-01-02",
            "original_text": "Johnson & Johnson Announces Chris DelOrefice as Vice President of Investor Relations",
            "features": {
                "keywords": [
                    "Johnson & Johnson",
                    "Chris DelOrefice",
                    "Vice President",
                    "Investor Relations"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 3,
                "Duration": 2,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-08-01",
            "original_text": "NYSE trader: Stocks could drop in August",
            "features": {
                "keywords": [
                    "NYSE",
                    "trader",
                    "Stocks",
                    "drop",
                    "August"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-08-02",
            "original_text": "VIVUS (VVUS) Q2 Loss Wider Than Expected, Revenues Up Y/Y",
            "features": {
                "keywords": [
                    "VIVUS",
                    "Q2",
                    "Loss",
                    "Wider",
                    "Revenues",
                    "Up",
                    "Y/Y"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 8,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-08-03",
            "original_text": "These Products Saw Falling Sales in Pfizerâ€™s Q2 2018",
            "features": {
                "keywords": [
                    "Pfizer",
                    "Products",
                    "Falling",
                    "Sales",
                    "Q2",
                    "2018"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-08-09",
            "original_text": "Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for August 09, 2018",
            "features": {
                "keywords": [
                    "Astrazeneca",
                    "PLC",
                    "Ex-Dividend",
                    "Date",
                    "Scheduled",
                    "August",
                    "09",
                    "2018"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 2,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]